# Sources — Ray Charles

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 3, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Jacobs H. “Ray Charles (1930–2004).” *New Georgia Encyclopedia* (Georgia Humanities), originally published May 15, 2003, last edited April 14, 2021. Supports his birth as Ray Charles Robinson in Albany on September 23, 1930; the move to Greenville, Florida; the loss of sight beginning at about age five, probably as a result of congenital juvenile glaucoma; the drowning of his younger brother the same year; his being declared legally blind at seven and his nine years at the Florida School for the Deaf and Blind in St. Augustine, until his mother’s death in 1945; his 1964 arrest for heroin possession and his later admission that he had been addicted since the late 1940s; his rehabilitation at a California sanitarium, after which he stopped using drugs and received a five-year suspended sentence; and his death on June 10, 2004, of acute liver disease at his home in Beverly Hills. https://www.georgiaencyclopedia.org/articles/arts-culture/ray-charles-1930-2004/
2. Breznican A. “Legendary musician Ray Charles dies at 73.” Associated Press, June 10, 2004 (Seattle Times archive). Supports his death at his Beverly Hills home of acute liver disease, as stated by his spokesman; that he was blind by age seven, about two years after his brother drowned; that “glaucoma is often mentioned as a cause, though Charles said nothing was ever diagnosed”; that he struggled with heroin for nearly 20 years and quit “cold turkey” in 1965 after an arrest at the Boston airport; and that he later became reluctant to discuss his drug use, fearing it would taint how people viewed his work. https://archive.seattletimes.com/archive/20040610/webraycharles10/legendary-musician-ray-charles-dies-at-73
3. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), glaucoma and depression, bipolar, and mood disorders monographs. Glaucoma: comprehensive eye examination, tonometry, OCT and visual fields, gonioscopy, adherence and ocular surface checks, and primary-care red-flag recognition, applied here only as far as they help blind eyes. Depression: PHQ-9 or PHQ-2 screening, suicide-risk reassessment, and the MDQ at a new depressive episode. https://patrickrutledge.github.io/topthirty/
2. American Academy of Ophthalmology. Primary Open-Angle Glaucoma Preferred Practice Pattern (2025). https://doi.org/10.1016/j.ophtha.2025.12.029
3. American Academy of Ophthalmology. Vision Rehabilitation Preferred Practice Pattern. *Ophthalmology* 2023. Offering vision rehabilitation to people with vision loss, and accessibility and safety at home. https://pubmed.ncbi.nlm.nih.gov/36543605/
4. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021). Recovery support, naloxone, and testing for hepatitis and HIV in people with a substance use disorder. https://www.healthquality.va.gov/guidelines/MH/sud/
5. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. *Journal of Addiction Medicine* 2020. Naloxone for overdose reversal and pain management in people with opioid use disorder. https://pubmed.ncbi.nlm.nih.gov/32511106/
6. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024). Structured risk assessment and safety planning. https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp
7. U.S. Preventive Services Task Force: depression and suicide risk screening (2023); falls prevention (2024); unhealthy alcohol use (2018); unhealthy drug use (2020); colorectal cancer (2021); statin use (2022); prostate cancer (2018); A and B recommendations. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
8. Centers for Medicare & Medicaid Services. Medicare Wellness Visits (Medicare Learning Network). https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html
9. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/
10. Centers for Disease Control and Prevention. Screening and Testing for Hepatitis B Virus Infection, 2023 (https://pubmed.ncbi.nlm.nih.gov/36893044/) and the Adult Immunization Schedule by Age (https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html).

## Editorial resolutions

- **Recent-death rule.** Charles died in 2004. The case uses only what Charles made public himself (his admission of his addiction after the 1964 arrest and his account that no cause of his blindness was ever diagnosed) and what was reported publicly at his death, from the New Georgia Encyclopedia and the AP obituary. No medical records, family accounts, biographers’ accounts of his private life, or speculation about undisclosed conditions are used. The recent-death review rule applies. Substance-use claims are marked sensitive.
- **Blindness and its cause.** That he lost his sight from about age five and was blind by seven is graded **D**. The cause is graded **R** with certainty possible: one source calls it most probably congenital juvenile glaucoma, the other says glaucoma is often mentioned but that Charles said nothing was ever diagnosed. Glaucoma is therefore not coded. The blindness is coded H54.0X55 (category 5, no light perception, both eyes); the sources say only “blind,” and category 5 is a synthetic grading that follows the case brief to treat him as totally blind. Reports that one eye was removed in childhood were found only in sources that were not reliable and disagree about which eye; they are not used. To avoid contradicting either possibility, no note describes the globes, pupils, corneas, or optic nerves, no eye pressure is measured, and the eye examinations record only acuity, lids, ocular surfaces, tenderness, and comfort.
- **Opioid use disorder.** His heroin addiction from the late 1940s, the 1964 arrest, and his recovery after rehabilitation in 1965 are documented and were admitted publicly; the AP adds that he later became reluctant to discuss it. The modern problem is coded F11.21 (opioid dependence, in remission) with placement both_with_link. The language is person-first and recovery-oriented; the clinician-written note text does not restate the arrest or the history beyond what care needs (the generated historical-basis sections list the claims as written), and the record describes no route of use. The problem is listed as active, because it is managed at every visit, with the remission carried by the code. The F11 code triggers the structured safety assessment, which records no current risk, gives the 988 Suicide & Crisis Lifeline in an accessible format, and is reviewed at each later visit. Naloxone is offered as routine care, not because of any current risk.
- **Arrest year.** The New Georgia Encyclopedia dates the arrest to 1964; the AP says he quit in 1965 after an arrest at the Boston airport. The two are consistent if the arrest preceded the 1965 rehabilitation, and the timeline records the arrest in 1964 and the recovery in 1965.
- **Index age.** The modern episode presents Charles at 65, more than thirty years into his recovery, so that the episode can teach sustained remission and the annual wellness visit. The synthetic date of birth is September 23, 1960 (shift 30 years). The index visit on March 3, 2026 maps to March 3, 1996; the chronic-care visits on March 31, June 2, and September 1, 2026 map to the same days of 1996; and the annual wellness visit on October 6, 2026 (age 66) maps to October 6, 1996, years before his final illness. Past medical history and family history include only events before the index date.
- **Liver.** He died of acute liver disease. The episode records no liver diagnosis and no liver tests, so that nothing reads as a claim about his liver health before that illness. Hepatitis C, hepatitis B, and HIV testing are ordered at the annual wellness visit as routine screening and no results are recorded. Failing to offer them at intake is recorded as a protocol deviation at the four-week visit.
- **Synthetic content.** Alcohol use (AUDIT-C 2), no tobacco, the DAST-10 and PHQ scores, the laboratory results, his travel and home routines, his use of a screen reader and a sighted guide, the naloxone, the pain plan, and the preventive care are synthetic. Biographers’ accounts of his drinking were not verified in a fetched source and are not used; the AUDIT-C is a routine synthetic screen and makes no claim about his real drinking. The relatives in the family history are recorded only with the facts the sources give, and no relative appears in the visit notes.
- **Annual wellness visit.** A subsequent Medicare annual wellness visit was added on October 6, 2026 (true frame October 6, 1996), five weeks after the six-month review. No sick visit was added: under the recent-death rule the case adds no synthetic illness episode. Judgment calls: (1) the health risk assessment is read aloud and answered by him directly, with the method recorded; (2) cognition is assessed by observation and a verbal three-word recall, because the clock-drawing part of the Mini-Cog is not valid for a blind patient; (3) advance care planning names an unnamed health care agent and records only general priorities (independence, his work, and his recovery), and deliberately records no treatment preference, so that nothing in it reads as a claim about his real choices; (4) the stool test and blood tests are ordered with no results recorded; (5) a statin is discussed and not started, because the USPSTF criteria are not met.
- **Focused visits.** The three chronic-care follow-ups (four weeks, three months, and six months after the first visit) are documented as focused visits. The CMID glaucoma monograph is applied only as far as it helps blind eyes: eye comfort and ocular surface checks every visit and a yearly comfort-focused examination are done, while tonometry, OCT, visual fields, gonioscopy, and drop adherence are marked not indicated with the reason. The CMID depression monograph sets the PHQ-9 at intake and six months and the PHQ-2 at the wellness visit; suicide-risk review follows the VA/DoD guideline at every visit. Recovery care follows the VA/DoD and ASAM guidance: a recovery check every visit, naloxone, a written plan for any future pain, and, as not indicated with reasons, medication for opioid use disorder and urine drug testing. Protocol deviation recorded instead of invented results: hepatitis C, hepatitis B, and HIV testing was not offered at intake; no harm is evident, and the tests are drawn at the wellness visit.
- **Consultation.** The ophthalmology referral and the consultation by Haruto Ishikawa, MD (a fictional consultant), on the day of the four-week visit, are **S**. The consultant answers the five referral questions with what the record shows afterwards: no active eye disease and no treatment, no routine pressure checks, imaging, or fields, a yearly comfort-focused review, same-day review for pain or redness, and vision rehabilitation offered and not wanted now. The consultant does not settle the cause of the blindness and records no glaucoma diagnosis.
- **Not used.** His 1978 autobiography, a 1973 magazine interview about his addiction, biographers’ accounts, the film about his life, accounts of his final illness, and reports that an eye was removed were not fetched or not reliable, and are not used. His height is not recorded in a fetched source; the 178 cm in the record is synthetic.
